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Oligodendrocyte progenitor cells (OPCs) hold great promise for treatment of dysmyelinating disorders, such as multiple sclerosis
and cerebral palsy. Recent studies on generation of human OPCs mainly use human embryonic stem cells (hESCs) or neural stem
cells (NSCs) as starter cell sources for the differentiation process. However, NSCs are restricted in availability and the present
method for generation of oligodendrocytes (OLs) from ESCs often requires a lengthy period of time. Here, we demonstrated a
protocol to efficiently derive OPCs from human induced pluripotent stem cells (hiPSCs) by forced expression of two transcription
factors (2TFs), Sox10 and Olig2. With this method, PDGFRα+ OPCs can be obtained in 14 days and O4+ OPCs in 56 days.
Furthermore, OPCs may be able to differentiate to mature OLs that could ensheath axons when co-cultured with rat cortical
neurons. The results have implications in the development of autologous cell therapies.
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INTRODUCTION
The loss of OLs and myelin in the central nervous system
(CNS) often causes substantial morbidity and mortality, such
as multiple sclerosis and leukodystrophies. Currently avail-
able treatments targeting the immune system are highly ef-
fective at reducing the intermittent episodes of inflammation,
but they do not influence the progressive course of disease
and the long-term prognosis is generally poor. OPCs can dif-
ferentiate into OLs which ensheath axons with myelin during
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brain development and remyelinate axons after brain damage.
Thus OPCs have been identified as a promising cell popu-
lation for therapeutic approaches in demyelinating diseases.
Many studies have been focused on differentiation of OPCs
from ESCs (Cloutier et al., 2006; Kang et al., 2007; Piao et
al., 2015) and NSCs (Hwang et al., 2009; Sher et al., 2009), or
generation of OPCs by direct lineage conversion for the treat-
ment of those diseases (Najm et al., 2013; Yang et al., 2013).
However, there are considerable drawbacks to the actual ap-
plication of these cells. Grafts of OPCs derived from hESCs
are allogeneic and may require immunosuppressive treatment
after transplantation, apart from the ethical concerns associ-
ated with hESCs. Human NSCs (hNSCs) exist at the subven-
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tricular zone (SVZ) of lateral ventricle wall in adult CNS, or
can be isolated from fetal brain. However, either case means
restricted availability.
Human iPSCs can be generated from many somatic cell
types; thus patient-specific iPSCs could offer an autologous
origin of OPCs. A recent paper suggests the feasibility of ob-
taining iPSCs-derived OPCs through an embryoid body (EB)
stage; however, it takes about four months to get a large num-
ber of PDGFRα+OPCs (Wang et al., 2013). Recently, Fossati
and Douvaras improved the differentiation protocol by using
monolayer culture on Matrigel, together with small molecule
treatment. In this way, generation of oligodendrocytes from
iPSCs can be shortened from 95 days to 75 days (Douvaras
and Fossati, 2015; Douvaras et al., 2014). We were inspired
by the report that functional induced neurons can be gener-
ated from hiPSCs within two weeks by forced expression of
a single transcription factor (Zhang et al., 2013). Sox10 and
Olig2 play key roles in OL specification (Cahoy et al., 2008;
Dugas et al., 2006; Goldman and Kuypers, 2015; Lu et al.,
2000; Stolt et al., 2004; Wang et al., 2014; Zhou et al., 2000),
and therefore were chosen in attempt to accelerate the gener-
ation of OPCs from hiPSCs.
In this study, we demonstrated a method of generating
PDGFRα+ pre-OPCs in less than two weeks, which could
be further maturated into O4+ late-OPCs. In addition, we
co-cultured induced OPCs (iOPCs) with rat cortical neurons
to examine the capacity to ensheath axons.
RESULTS
Generation of iOPCs within two weeks
To accelerate the speed of OPC generation, we designed
an experimental procedure (Figure 1A) to direct iPSCs into
iOPCs by forced expression of Sox10 and Olig2. Following
infection of virus encocoding Sox10 and Olig2 and selection
with hygromycin, about 60% of cells were co-infected with
the 2TFs (Sox10 and Olig2), as evidenced by immunos-
taining against Sox10 and Olig2 (data not shown). After
infection with 2TFs and treated with OPC medium, a marked
morphological change from typical iPSCs to bipolar cells
was shown within two weeks (Figure 1B–E). A subpopula-
tion of the iPSCs-derived cells could proliferate in response
to OPC medium added with PDGF and stained positive for
PDGFRα—a defined specific marker for OPC (Sim et al.,
2011; Wang et al., 2013), which was not expressed by iPSCs
(Figure 1F). At day 14, a large proportion of cells were
labeled with PDGFRα owing to the combination of Sox10
and Olig2 compared with negative control infected with
iDuet101-GFP only (Figure 1G–I).
Combination of Sox10 and Olig2 is better than either fac-
tor alone in iOPC generation
To examine whether a single transcription factor (Sox10 or
Olig2) is sufficient to promote the generation of iOPCs, we
set up four experimental groups, (A) Sox10, (B) Olig2, (C)
Sox10 and Olig2, and (D) negative controls (NC) without
virus infection. At day 15, we observed OPC-like cells with
a bipolar morphology (Figure 2A–D) and the iOPCs could
proliferate in response to PDGF-AB and bFGF (Pang et al.,
2013) from groups with viral infection. Cells from the four
groups were stained for PDGFRα. The results showed that
the proportion of PDGFRα+ cells from Sox10+Olig2 group
was more than that of single factor groups, which was fur-
ther higher than that of negative control group (Figure 2E–H,
M). To investigate the differential capacity of iOPCs, cells
were exposed to differential condition containing T3, NT3,
IGF-1 (known to be beneficial for oligodendrocyte differen-
tiation or survival) (Douvaras and Fossati, 2015; Najm et al.,
2013; Pang et al., 2013). Cells were stained with O4 antibod-
ies (Douvaras and Fossati, 2015; Pang et al., 2013; Yang et al.,
2013) every other week to test whether induced oligodendro-
cytes (iOLs) had appeared. At the fourth week of differenti-
ation, around 42% of cells were O4-positive in Sox10+Olig2
group, higher than that of single factor groups and the nega-
tive group (Figure 2I–L, N).
The endogeneous gene expression was examined by using
RT-PCR. Along the course of differentiation, iPSC-related
genes OCT4, NANOG, and SOX2 were shut down, and OPC-
and OL-related genes were turned on (Figure 3A–D), con-
firming that the cells in the three groups had committed to
the oligodendrocyte lineage at the molecular level. The ex-
ogenous gene expression was also monitored, which was still
detectable at day 15, but the transgenes were gradually si-
lenced afterwards (Figure 3E).
To further confirm the generation of iOPCs and iOLs from
the Sox10+Olig2 group, we stained the cells with additional
markers of OPC and OL such as NKX2.2, A2B5 (Wang
et al., 2013; Yang et al., 2013), O1 and CNPase, using the
experimental procedure described in Figure 1A. Then we
observed proliferative cells in response to growth factors
with bipolar, OPC-like morphologies (Figure 4A). Cells were
stained with NKX2.2, A2B5, PDGFRα and NG2 (specific
markers of OPCs) in an attempt to verify the generation of
iOPCs (Figure 4C–E). The proportion of A2B5+/PDGFRα+
double positive cells was about 18% at day 14. Also, GFAP+
astrocytes could be generated during the differentiation
(Figure 4F). After eight weeks of differentiation, many
processes took shape in induced cells (Figure 4B), and the
cells were positive for O1, CNPase and O4 (markers of OL
lineage) (Figure 4G–J), suggesting that OLs might have been
differentiated from hiPSCs by forced expression of 2TFs
(Sox10 and Olig2).
iOPCs may generate iOLs when co-cultured with cortical
neurons in vitro
To evaluate the myelinating function of iOLs obtained from
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Figure 1   (Color online) Acceralted generation of iOPCs. A, Diagram of iOPC generation. B–E, Morphology changes from iPSCs to iOPCs by infection with
2TFs. B, hiPSCs before adding virus. C, hiPSCs infected with virus for 36 h. D, cells passaged on PDL/LMN. E, morphology of iOPCs at day 14. F, iPSCs
stained negative for PDGFRα. G, iPSCs infected with iDuet101-GFP at differentiation day 14 were negative for PDGFRα. H, iPSCs infected with Sox10 and
Olig2 at differentiation day 14. I, the proportion of PDGFRα-positive cells in Sox10+Olig2 group was significantly higher than that of control group at day 14.
***, P<0.001; Blue in F–H, Hoechst; Red in F–H, PDGFRα; Scale bars, 200 μm (B–E), 100 μm (F), and 75 μm (G and H). TF, transcription factor.
Li, P., et al.   Sci China Life Sci   November (2016)  Vol. 59  No. 11 1133
Figure 2   (Color online) Efficiency of iOPC generation in different groups. A–D, The morphology of cells from the four groups at day 15. Sox10 (A), Olig2
(B), Sox10+Olig2 (C), none-virus control (D), Scale bars, 200 μm. E–N, The proportions of PDGFRα– and O4-positive cells in Sox10+Olig2 group were
significantly higher than those of other groups at day 15 and 56. E–L, Sox10 (E and I), Olig2 (F and J), Sox10+Olig2 (G and K), none-virus control (H and L).
PDGFRα (red), O4 (green), Hoechst (blue), Scale bars, 50 μm. (M and N) two tailed t test; ***, P<0.001; **, P<0.01.
hiPSCs, induced cells were co-cultured with rat cortical
neurons isolated at embryonic day 17 (E17). Cortical neu-
rons (about 4×105) were seeded on coverslips coated with
PDL/Lamnin and were treated with Ara-c for four days.
Meanwhile, iOPCs were infected with iDuet101-GFP at day
21 of differentiation. Then GFP-expressing iOPCs (about
1×105) were plated onto cortical neurons and cultured in
differentiation medium. Cells were fixed and stained at day 7
and 14 after co-culture. At day 7 in co-culture, some seeded
cells (GFP+) showed morphology with complex processes
and stained positive for the OL marker O4 (Figure 5A–C).
At day 7 in co-culture, the proportion  of  O4-positive iOLs
1134 Li, P., et al.   Sci China Life Sci   November (2016)  Vol. 59  No. 11
Figure 3   RT-PCR analysis of endogenous and exogenous factor expression. A, RT-PCR analysis of endogenous expression of iPSC-related genes
OCT4/NANOG/SOX2, and OPC-related genes OLIG2/PDGFRΑ, and OL-related gene CNPase. B–D, Relative expression levels of OLIG2 (B), PDGFRα (C)
and CNPase (D) normalized with β-ACTIN expression. E, RT-PCR analysis of exogenous factor expression (SOX10 and OILG2) in the three experimental
groups.
was about 5%, and the ratio of OLs with typical morphology
(with arborized processes) to those with aberrant morphology
(flattened with few processes) was about 1:2. Compared with
direct differentiation from iOPCs without co-culture, co-cul-
ture with cortical neurons may have sped up the generation
of iOLs. At day 14 in co-culture, around 0.5% of rat cortical
neurons (Tuj-1+ and GFP–) had axons co-labeled with the pro-
cesses of iOLs (GFP+) (Figure 5D). The results indicate that
the obtained iOLs using two factors might possess the capac-
ity to myelinate axons.
DISCUSSION
In this study, we described a protocol to convert hiPSCs
into OPCs by forced expression of two transcription factors,
Sox10 and Olig2. Introduction of these two factors markedly
accelerated the generation of OPCs and the efficiency was
higher with two combined factors than that with each indi-
vidual factor.
A recent study published by Wernig’s group (Yang et al.,
2013) reported that three factors, Sox10, Olig2, and Zfp536
are sufficient to reprogram rodent fibroblasts into OPCs. In
another study published from Tesar’s lab (Najm et al., 2013),
it was shown that Sox10, Olig2, and Nkx6.2 are capable of
converting mouse fibroblasts into OPCs. In both studies,
Sox10 and Olig2 were included in the three factor combina-
tion, suggesting their central roles in OPC development and
maintainence. Different cell types in a way reflect a certain
functional state governed by a network of factors/proteins.
A master factor may reset the network by feed-forward and
feed-back signaling pathways and therefore lead to a different
functional state/cell type. Inspired by the finding that a single
factor can signigicantly accelerate neuronal induction from
ES cells, we reasoned that Sox10 and Olig2 may also speed
up the conversion of iPSCs into OPCs, given the key func-
tions of these two factors. Indeed, in the current study, we
found that Sox10 and Olig2 can reduce the otherwise lengthy
differentiation process to two weeks. However, it is still un-
clear whether the OPCs obtained this way are the same as the
primary OPCs and/or ESC-derived OPCs through EB stage.
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Figure 4   (Color online) Generation of iOLs from hiPSCs. A and B, The
morphology of iOPCs at day 14 (A) and day 56 (B). C, Nkx2.2 (red). D,
merged staining results for A2B5 (green) and PDGFRα (red). E, merged
staining results for NG2 (green) and CNPase (red). F, GFAP (red). G, O1
(red). H, CNPase (green). I, O4 (red). J, CNPase (red), Hoechst (blue).
Scale bars, 200 μm (A), 100 μm (B and C), 75 μm (D), 50 μm (E–G), 25 μm
(H–J).
Further studies applying gene expression profiling and in vivo




The coding regions of Sox10 and Olig2 were amplified by
PCR using human cDNA as templates, and then cloned into
Kpn І/BsrG І site of the iDuet101 plasmid, respectively (Zhou
et al., 2007). The constructed vectors were transformed into
E. coli DH5α for expansion followed by extraction and se-
quence confirmation.
Production of lentivirus
Lentiviruses were produced according to a previously pub-
lished study (Sheng et al., 2012). Briefly, HEK293T cells
were cultured in OPTi-MEM supplemented with VSVG, delt
8.74, recombiant plasmid and lipo2000. After 8 h, OPTi-
MEMwas replaced with 293Tmedium consisting of DMEM,
FBS, PS and Glutamax. Three days later, supernatant con-
taining lentivirus was harvested and concentrated by centrifu-
gation after filtering with 0.45 μm PVDF membrane.
Generation of iOPCs from human iPSCs
Human iPSCs, a gift from our colleague in our own lab (Wang
et al., 2015), were plated in matrigel-coated six-well-culture
plate and cultured in E8 medium (special medium for iPSCs).
Upon about 30% confluence, media containning lentivirus
and 4 μg mL–1 polybrene were mixed and added freshly onto
hiPSCs. Viral medium was changed after 36 h and replaced
with E8 medium to assist the recovery of hiPSCs (Figure 1C).
The day when the virus was discarded was termed “Day 0”.
iDuet101 was contructed to include a Hygro gene, which can
be used for selection with hygromycin starting on Day 1. On
Day 1, E8 medium was replaced with iOPCs basic medium
consisting of DMEM/F12, N2, B27 without vitamin A, and
glutamax, supplemented with 3 μmol L–1 dorsomorphin and
1 μmol L–1 RA (Jiang et al., 2010) for five days. When the
cells of negative control without virus infection all died by hy-
gromycin treatment, hygromycin was removed from the ex-
perimental group. At day 6, cells were transferred onto cov-
erslips coated with poly-D-lycin(PDL)-laminin by treatment
with accutase. As is shown in the flow diagram (Figure 1A),
the following molecules were used: 20 ng mL–1 platelet-de-
rived growth factor-AB (PDGF-AB), 20 ng mL–1 basic fi-
broblast growth factor (bFGF), 60 ng mL–1 thriiodo-L-thy-
tonine (T3), 10 ng mL–1 neurotrophin 3 (NT3), 1 μmol L–1
purmophamine (Pur), 10 ngmL–1 insulin-like growth factor-1
(IGF-1) and 1 μmol L–1 cAMP.
Immunofluorescence
Cells were washed twice in PBS and fixed with 4%
paraformaldehyde (PFA) for 15 min at room temperature
(RT). Then cells were immersed in blocking buffer con-
sisting of 0.3% Triton X-100 and 3% donkey serum for at
least 1 h, then incubated with primary antibodies overnight
at 4°C. The following primary antibodies were used: rabbit
anti-PDGFRα (Santa Cruz, USA, 1:200), rabbit anti-CN-
Pase (Multi Science, USA, 1:200), rabbit anti-NKX2.2
(Santa Cruz, 1:200), rabbit anti-GFAP (Beijing Zhong
Shan-Golden Bridge, 1:100), rabbit anti-Olig2 (Millipore,
USA, 1:500), mouse anti-NG2 (Abcam, USA, 1:100), mouse
anti-A2B5 (Abcam, 1:800), mouse anti-O1 (eBioscience,
USA, 1:100), mouse anti-O4 (R&D Systems, USA, 1:400),
mouse anti-Tuj-1(Millipore, 1:400), goat anti-Sox10 (Santa
Cruz, 1:50). Next, cells were incubated with secondary anti-
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Figure 5   (Color online) iOPCs co-cultured with rat cortical neurons. A–C, co-culture at day 7, merged staining results for GFP (green) and O4 (red). D,
co-culture at day 14, merged staining results for GFP (green) and Tuj-1 (red). Scale bars, 50 μm (A and B), 25 μm (C), 75 μm (D).
bodies for 2 h at RT. Omission of primary antibodies served
as negative controls.
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